Tamarack Advisers as of Dec. 31, 2016
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 27 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 7.5 | $106M | 850k | 124.40 | |
| NxStage Medical | 6.8 | $96M | 368k | 262.10 | |
| Hologic (HOLX) | 6.5 | $92M | 230k | 401.20 | |
| Bio-Rad Laboratories (BIO) | 6.3 | $89M | 49k | 1822.80 | |
| Pacira Pharmaceuticals (PCRX) | 6.2 | $88M | 273k | 323.00 | |
| Jazz Pharmaceuticals (JAZZ) | 5.9 | $84M | 77k | 1090.30 | |
| Spectranetics Corporation | 5.7 | $81M | 330k | 245.00 | |
| Allscripts Healthcare Solutions (MDRX) | 5.5 | $78M | 765k | 102.10 | |
| Gilead Sciences (GILD) | 5.1 | $72M | 100k | 716.10 | |
| Teladoc (TDOC) | 4.8 | $69M | 416k | 165.00 | |
| Laboratory Corp. of America Holdings (LH) | 4.6 | $66M | 51k | 1283.80 | |
| Novocure Ltd call | 4.6 | $65M | 825k | 78.50 | |
| Cardiome Pharma | 3.6 | $50M | 1.8M | 27.60 | |
| Obalon Therapeutics | 3.5 | $50M | 563k | 88.50 | |
| Amgen (AMGN) | 3.2 | $45M | 31k | 1462.10 | |
| Alkermes (ALKS) | 3.1 | $43M | 78k | 555.79 | |
| athenahealth | 3.0 | $43M | 41k | 1051.71 | |
| Steris Corporation | 3.0 | $43M | 63k | 673.90 | |
| Service Corporation International (SCI) | 2.5 | $36M | 125k | 284.00 | |
| Impax Laboratories | 2.4 | $34M | 258k | 132.50 | |
| Corium Intl | 2.1 | $30M | 737k | 40.60 | |
| Luminex Corporation | 1.9 | $27M | 135k | 202.30 | |
| Streamline Health Solutions (STRM) | 1.0 | $14M | 1.1M | 12.50 | |
| Boston Scientific Corporation (BSX) | 0.5 | $6.3M | 2.2k | 2885.00 | |
| Quotient | 0.3 | $4.8M | 100k | 48.40 | |
| Henry Schein (HSIC) | 0.1 | $1.6M | 360.00 | 4550.00 | |
| Stryker Corporation (SYK) | 0.0 | $269k | 250.00 | 1076.00 |
